메뉴 건너뛰기




Volumn 70, Issue 2, 2014, Pages 147-154

Tadalafil-induced improvement in left ventricular diastolic function in resistant hypertension

Author keywords

Left ventricular diastolic function; PDE5 inhibitors; Refractory hypertension

Indexed keywords

AGED; BLOOD PRESSURE; CARBOLINES; CROSS-OVER STUDIES; CYCLIC GMP; DIASTOLE; DRUG RESISTANCE; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NITRITES; PHOSPHODIESTERASE 5 INHIBITORS; SINGLE-BLIND METHOD; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84895076464     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-013-1611-8     Document Type: Article
Times cited : (18)

References (35)
  • 1
    • 79959334521 scopus 로고    scopus 로고
    • Resistant hypertension: Diagnosis, evaluation, and treatment: A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research
    • 18574054 10.1161/CIRCULATIONAHA.108.189141
    • Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM (2008) Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 117:e510-e526
    • (2008) Circulation , vol.117
    • Calhoun, D.A.1    Jones, D.2    Textor, S.3    Goff, D.C.4    Murphy, T.P.5    Toto, R.D.6    White, A.7    Cushman, W.C.8    White, W.9    Sica, D.10    Ferdinand, K.11    Giles, T.D.12    Falkner, B.13    Carey, R.M.14
  • 2
    • 77951591235 scopus 로고    scopus 로고
    • Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension
    • 20435193 10.1016/j.ahj.2010.02.012
    • Salles GF, Cardoso CR, Fiszman R, Muxfeldt ES (2010) Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension. Am Heart J 159:833-840
    • (2010) Am Heart J , vol.159 , pp. 833-840
    • Salles, G.F.1    Cardoso, C.R.2    Fiszman, R.3    Muxfeldt, E.S.4
  • 3
    • 0037425535 scopus 로고    scopus 로고
    • Burden of systolic and diastolic ventricular dysfunction in the community: Appreciating the scope of the heart failure epidemic
    • 12517230 10.1001/jama.289.2.194
    • Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ (2003) Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289:194-202
    • (2003) JAMA , vol.289 , pp. 194-202
    • Redfield, M.M.1    Jacobsen, S.J.2    Burnett, Jr.J.C.3    Mahoney, D.W.4    Bailey, K.R.5    Rodeheffer, R.J.6
  • 7
    • 33750579081 scopus 로고    scopus 로고
    • Effect of regular phosphodiesterase type 5 inhibition in hypertension
    • 1:CAS:528:DC%2BD28XpsFOrsL8%3D 16940217 10.1161/01.HYP.0000239816.13007. c9
    • Oliver JJ, Melville VP, Webb DJ (2006) Effect of regular phosphodiesterase type 5 inhibition in hypertension. Hypertension 48:622-627
    • (2006) Hypertension , vol.48 , pp. 622-627
    • Oliver, J.J.1    Melville, V.P.2    Webb, D.J.3
  • 8
    • 67049155295 scopus 로고    scopus 로고
    • Blood pressure lowering effects of a new long-acting inhibitor of phosphodiesterase 5 in patients with mild to moderate hypertension
    • 1:CAS:528:DC%2BD1MXlslCitbk%3D 19398651 10.1161/HYPERTENSIONAHA.109. 132225
    • Wolk R, Smith WB, Neutel JM, Rubino J, Xuan D, Mancuso J, Gilbert J, Pressler ML (2009) Blood pressure lowering effects of a new long-acting inhibitor of phosphodiesterase 5 in patients with mild to moderate hypertension. Hypertension 53:1091-1097
    • (2009) Hypertension , vol.53 , pp. 1091-1097
    • Wolk, R.1    Smith, W.B.2    Neutel, J.M.3    Rubino, J.4    Xuan, D.5    Mancuso, J.6    Gilbert, J.7    Pressler, M.L.8
  • 9
    • 77953807828 scopus 로고    scopus 로고
    • Clinical potential of combined organic nitrate and phosphodiesterase type 5 inhibitor in treatment-resistant hypertension
    • 1:CAS:528:DC%2BC3cXnsFGktbo%3D 20479335 10.1161/HYPERTENSIONAHA.109. 147686
    • Oliver JJ, Hughes VE, Dear JW, Webb DJ (2010) Clinical potential of combined organic nitrate and phosphodiesterase type 5 inhibitor in treatment-resistant hypertension. Hypertension 56:62-67
    • (2010) Hypertension , vol.56 , pp. 62-67
    • Oliver, J.J.1    Hughes, V.E.2    Dear, J.W.3    Webb, D.J.4
  • 12
    • 80052165627 scopus 로고    scopus 로고
    • Sildenafil preserves diastolic relaxation after reduction by L-NAME and increases phosphodiesterase-5 in the intercalated discs of cardiac myocytes and arterioles
    • 10.1590/S1807-59322011000700022
    • Ferreira-Melo SE, Demacq C, Lacchini S, Krieger JE, Irigoyen MC, Moreno H (2011) Sildenafil preserves diastolic relaxation after reduction by L-NAME and increases phosphodiesterase-5 in the intercalated discs of cardiac myocytes and arterioles. Clinics (Sao Paulo) 66:1253-1258
    • (2011) Clinics (Sao Paulo) , vol.66 , pp. 1253-1258
    • Ferreira-Melo, S.E.1    Demacq, C.2    Lacchini, S.3    Krieger, J.E.4    Irigoyen, M.C.5    Moreno, H.6
  • 17
    • 29244432482 scopus 로고    scopus 로고
    • Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology
    • 16376782 10.1016/j.echo.2005.10.005
    • Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440-1463
    • (2005) J Am Soc Echocardiogr , vol.18 , pp. 1440-1463
    • Lang, R.M.1    Bierig, M.2    Devereux, R.B.3    Flachskampf, F.A.4    Foster, E.5    Pellikka, P.A.6    Picard, M.H.7    Roman, M.J.8    Seward, J.9    Shanewise, J.S.10    Solomon, S.D.11    Spencer, K.T.12    Sutton, M.S.13    Stewart, W.J.14
  • 18
    • 0037443576 scopus 로고    scopus 로고
    • Impact of left ventricular ejection fraction on estimation of left ventricular filling pressures using tissue Doppler and flow propagation velocity
    • 12633827 10.1016/S0002-9149(02)03433-1
    • Rivas-Gotz C, Manolios M, Thohan V, Nagueh SF (2003) Impact of left ventricular ejection fraction on estimation of left ventricular filling pressures using tissue Doppler and flow propagation velocity. Am J Cardiol 91:780-784
    • (2003) Am J Cardiol , vol.91 , pp. 780-784
    • Rivas-Gotz, C.1    Manolios, M.2    Thohan, V.3    Nagueh, S.F.4
  • 19
    • 79551580284 scopus 로고    scopus 로고
    • PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: Results of a 1-year, prospective, randomized, placebo-controlled study
    • 1:CAS:528:DC%2BC3MXislKqt7Y%3D 21036891 10.1161/CIRCHEARTFAILURE.110. 944694
    • Guazzi M, Vicenzi M, Arena R, Guazzi MD (2011) PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study. Circ Heart Fail 4:8-17
    • (2011) Circ Heart Fail , vol.4 , pp. 8-17
    • Guazzi, M.1    Vicenzi, M.2    Arena, R.3    Guazzi, M.D.4
  • 21
    • 27444439573 scopus 로고    scopus 로고
    • Sildenafil inhibits beta-adrenergic-stimulated cardiac contractility in humans
    • 1:CAS:528:DC%2BD2MXhtFajtLrL 16246964 10.1161/CIRCULATIONAHA.105.540500
    • Borlaug BA, Melenovsky V, Marhin T, Fitzgerald P, Kass DA (2005) Sildenafil inhibits beta-adrenergic-stimulated cardiac contractility in humans. Circulation 112:2642-2649
    • (2005) Circulation , vol.112 , pp. 2642-2649
    • Borlaug, B.A.1    Melenovsky, V.2    Marhin, T.3    Fitzgerald, P.4    Kass, D.A.5
  • 22
    • 77956283047 scopus 로고    scopus 로고
    • CGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action
    • 1:CAS:528:DC%2BC3cXhsVSltbbL 20716671 10.1124/pr.110.002907
    • Francis SH, Busch JL, Corbin JD, Sibley D (2010) cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol Rev 62:525-563
    • (2010) Pharmacol Rev , vol.62 , pp. 525-563
    • Francis, S.H.1    Busch, J.L.2    Corbin, J.D.3    Sibley, D.4
  • 23
    • 33748746141 scopus 로고    scopus 로고
    • Cardiovascular effects of phosphodiesterase 5 inhibitors
    • 1:CAS:528:DC%2BD28XhtVGlt7%2FE 17017941 10.2174/138161206778343073
    • Reffelmann T, Kloner RA (2006) Cardiovascular effects of phosphodiesterase 5 inhibitors. Curr Pharm Des 12:3485-3494
    • (2006) Curr Pharm des , vol.12 , pp. 3485-3494
    • Reffelmann, T.1    Kloner, R.A.2
  • 25
    • 0026570943 scopus 로고
    • Direct evidence for cross-activation of cGMP-dependent protein kinase by cAMP in pig coronary arteries
    • 1:CAS:528:DyaK38XotFWkuw%3D%3D 1309758
    • Jiang H, Colbran JL, Francis SH, Corbin JD (1992) Direct evidence for cross-activation of cGMP-dependent protein kinase by cAMP in pig coronary arteries. J Biol Chem 267:1015-1019
    • (1992) J Biol Chem , vol.267 , pp. 1015-1019
    • Jiang, H.1    Colbran, J.L.2    Francis, S.H.3    Corbin, J.D.4
  • 26
    • 67649083652 scopus 로고    scopus 로고
    • Phosphodiesterase 5 restricts NOS3/Soluble guanylate cyclase signaling to L-type Ca2+ current in cardiac myocytes
    • 1:CAS:528:DC%2BD1MXnsl2it7g%3D 2703689 19345227 10.1016/j.yjmcc.2009.03. 021
    • Wang H, Kohr MJ, Traynham CJ, Ziolo MT (2009) Phosphodiesterase 5 restricts NOS3/Soluble guanylate cyclase signaling to L-type Ca2+ current in cardiac myocytes. J Mol Cell Cardiol 47:304-314
    • (2009) J Mol Cell Cardiol , vol.47 , pp. 304-314
    • Wang, H.1    Kohr, M.J.2    Traynham, C.J.3    Ziolo, M.T.4
  • 27
    • 0032519668 scopus 로고    scopus 로고
    • Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts
    • 1:CAS:528:DyaK1cXht1Wrtrs%3D 508629 9466976 10.1172/JCI119883
    • Calderone A, Thaik CM, Takahashi N, Chang DL, Colucci WS (1998) Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J Clin Invest 101:812-818
    • (1998) J Clin Invest , vol.101 , pp. 812-818
    • Calderone, A.1    Thaik, C.M.2    Takahashi, N.3    Chang, D.L.4    Colucci, W.S.5
  • 28
    • 36349033482 scopus 로고    scopus 로고
    • Phosphodiesterase type 5: Expanding roles in cardiovascular regulation
    • 1:CAS:528:DC%2BD2sXhtlahurjJ 18040025 10.1161/CIRCRESAHA.107.162511
    • Kass DA, Champion HC, Beavo JA (2007) Phosphodiesterase type 5: expanding roles in cardiovascular regulation. Circ Res 101:1084-1095
    • (2007) Circ Res , vol.101 , pp. 1084-1095
    • Kass, D.A.1    Champion, H.C.2    Beavo, J.A.3
  • 29
    • 45149110626 scopus 로고    scopus 로고
    • The role of N terminal pro-brain natriuretic peptide in the evaluation of left ventricular diastolic dysfunction: Correlation with echocardiographic indexes in hypertensive patients
    • 17687631 10.1007/s10554-007-9256-2
    • Ceyhan C, Unal S, Yenisey C, Tekten T, Ceyhan FB (2008) The role of N terminal pro-brain natriuretic peptide in the evaluation of left ventricular diastolic dysfunction: correlation with echocardiographic indexes in hypertensive patients. Int J Cardiovasc Imaging 24:253-259
    • (2008) Int J Cardiovasc Imaging , vol.24 , pp. 253-259
    • Ceyhan, C.1    Unal, S.2    Yenisey, C.3    Tekten, T.4    Ceyhan, F.B.5
  • 30
    • 0031862908 scopus 로고    scopus 로고
    • Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
    • 1:STN:280:DyaK1c3kslyhtA%3D%3D 9588412 10.1016/S0002-8703(98)70041-9
    • Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M (1998) Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 135:825-832
    • (1998) Am Heart J , vol.135 , pp. 825-832
    • Maeda, K.1    Tsutamoto, T.2    Wada, A.3    Hisanaga, T.4    Kinoshita, M.5
  • 31
    • 84884909935 scopus 로고    scopus 로고
    • Prevalence, clinical characteristics, and outcomes associated with eccentric versus concentric left ventricular hypertrophy in heart failure with preserved ejection fraction
    • 23810323 10.1016/j.amjcard.2013.05.061
    • Katz DH, Beussink L, Sauer AJ, Freed BH, Burke MA, Shah SJ (2013) Prevalence, clinical characteristics, and outcomes associated with eccentric versus concentric left ventricular hypertrophy in heart failure with preserved ejection fraction. Am J Cardiol 112:1158-1164
    • (2013) Am J Cardiol , vol.112 , pp. 1158-1164
    • Katz, D.H.1    Beussink, L.2    Sauer, A.J.3    Freed, B.H.4    Burke, M.A.5    Shah, S.J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.